Turku, Finland

Piia Hara

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Oy. Active years: 2023.


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Piia Hara - Innovator in Therapeutic Release Technologies

Introduction

Piia Hara is a notable inventor based in Turku, Finland. She has made significant contributions to the field of therapeutic agents through her innovative methods. Her work focuses on enhancing the release of therapeutically active agents from elastomeric matrices.

Latest Patents

Hara holds a patent for a method that modifies the release of a therapeutically active agent from an elastomeric matrix. The patent describes a process that involves providing a core made of an elastomeric matrix and a therapeutically active agent. The core is then dipped into a coating solution of elastomer, which contains a specific percentage of filler. The method allows for continuous dipping, ensuring a consistent coating thickness. The fillers used can include silica, titanium dioxide, barium sulfate, carbon, and their mixtures. The elastomers selected for both the core and the coating solution are versatile, including poly(dimethyl) siloxanes, polyethylene vinyl acetates, polyurethanes, polyhydroxyethyl methacrylates, and polymethyl methacrylates.

Career Highlights

Piia Hara is currently employed at Bayer Oy, where she continues to develop her innovative ideas. Her work has the potential to significantly impact the pharmaceutical industry by improving drug delivery systems.

Collaborations

Hara collaborates with talented colleagues, including Manja Ahola and Jyrki Pihlaja, who contribute to her research and development efforts.

Conclusion

Piia Hara is a pioneering inventor whose work in modifying the release of therapeutically active agents showcases her commitment to advancing medical technologies. Her contributions are poised to enhance the effectiveness of drug delivery systems in the healthcare sector.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…